nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—nervous system—acquired immunodeficiency syndrome	0.005	0.0838	CbGeAlD
Roflumilast—PDE4C—central nervous system—acquired immunodeficiency syndrome	0.00481	0.0806	CbGeAlD
Roflumilast—PDE4D—lung—acquired immunodeficiency syndrome	0.00475	0.0796	CbGeAlD
Roflumilast—PDE4A—lung—acquired immunodeficiency syndrome	0.0042	0.0705	CbGeAlD
Roflumilast—PDE4C—brain—acquired immunodeficiency syndrome	0.00382	0.064	CbGeAlD
Roflumilast—PDE4D—brain—acquired immunodeficiency syndrome	0.00336	0.0564	CbGeAlD
Roflumilast—PDE4D—lymph node—acquired immunodeficiency syndrome	0.00325	0.0545	CbGeAlD
Roflumilast—PDE4B—lymphoid tissue—acquired immunodeficiency syndrome	0.00304	0.0509	CbGeAlD
Roflumilast—PDE4A—brain—acquired immunodeficiency syndrome	0.00297	0.0499	CbGeAlD
Roflumilast—PDE4A—lymph node—acquired immunodeficiency syndrome	0.00287	0.0482	CbGeAlD
Roflumilast—PDE4B—blood—acquired immunodeficiency syndrome	0.00286	0.0479	CbGeAlD
Roflumilast—PDE4B—bone marrow—acquired immunodeficiency syndrome	0.00277	0.0464	CbGeAlD
Roflumilast—PDE4B—spinal cord—acquired immunodeficiency syndrome	0.00275	0.0462	CbGeAlD
Roflumilast—PDE4B—vagina—acquired immunodeficiency syndrome	0.00265	0.0444	CbGeAlD
Roflumilast—PDE4B—lung—acquired immunodeficiency syndrome	0.00251	0.042	CbGeAlD
Roflumilast—PDE4B—nervous system—acquired immunodeficiency syndrome	0.00232	0.0389	CbGeAlD
Roflumilast—PDE4B—central nervous system—acquired immunodeficiency syndrome	0.00223	0.0375	CbGeAlD
Roflumilast—PDE4B—brain—acquired immunodeficiency syndrome	0.00177	0.0297	CbGeAlD
Roflumilast—PDE4B—lymph node—acquired immunodeficiency syndrome	0.00171	0.0287	CbGeAlD
Roflumilast—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00149	0.00159	CcSEcCtD
Roflumilast—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00149	0.00159	CcSEcCtD
Roflumilast—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00149	0.00159	CcSEcCtD
Roflumilast—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00149	0.00158	CcSEcCtD
Roflumilast—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00149	0.00158	CcSEcCtD
Roflumilast—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00149	0.00158	CcSEcCtD
Roflumilast—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00149	0.00158	CcSEcCtD
Roflumilast—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00148	0.00158	CcSEcCtD
Roflumilast—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00158	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00148	0.00158	CcSEcCtD
Roflumilast—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00148	0.00158	CcSEcCtD
Roflumilast—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00157	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00148	0.00157	CcSEcCtD
Roflumilast—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00148	0.00157	CcSEcCtD
Roflumilast—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00157	CcSEcCtD
Roflumilast—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00147	0.00157	CcSEcCtD
Roflumilast—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00147	0.00157	CcSEcCtD
Roflumilast—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00147	0.00157	CcSEcCtD
Roflumilast—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00147	0.00156	CcSEcCtD
Roflumilast—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00147	0.00156	CcSEcCtD
Roflumilast—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00156	CcSEcCtD
Roflumilast—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00146	0.00155	CcSEcCtD
Roflumilast—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00155	CcSEcCtD
Roflumilast—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00154	CcSEcCtD
Roflumilast—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00144	0.00153	CcSEcCtD
Roflumilast—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00153	CcSEcCtD
Roflumilast—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00143	0.00152	CcSEcCtD
Roflumilast—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00152	CcSEcCtD
Roflumilast—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00143	0.00152	CcSEcCtD
Roflumilast—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00143	0.00152	CcSEcCtD
Roflumilast—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.00142	0.00151	CcSEcCtD
Roflumilast—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.00151	CcSEcCtD
Roflumilast—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.0015	CcSEcCtD
Roflumilast—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.0015	CcSEcCtD
Roflumilast—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.0014	0.00149	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.0014	0.00149	CcSEcCtD
Roflumilast—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.0014	0.00149	CcSEcCtD
Roflumilast—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.0014	0.00149	CcSEcCtD
Roflumilast—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.0014	0.00149	CcSEcCtD
Roflumilast—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.0014	0.00149	CcSEcCtD
Roflumilast—Tension—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00148	CcSEcCtD
Roflumilast—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.00148	CcSEcCtD
Roflumilast—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00148	CcSEcCtD
Roflumilast—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00148	CcSEcCtD
Roflumilast—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00139	0.00148	CcSEcCtD
Roflumilast—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00148	CcSEcCtD
Roflumilast—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00147	CcSEcCtD
Roflumilast—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00147	CcSEcCtD
Roflumilast—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00147	CcSEcCtD
Roflumilast—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00138	0.00147	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00138	0.00147	CcSEcCtD
Roflumilast—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00146	CcSEcCtD
Roflumilast—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00137	0.00146	CcSEcCtD
Roflumilast—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.00146	CcSEcCtD
Roflumilast—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00137	0.00145	CcSEcCtD
Roflumilast—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00137	0.00145	CcSEcCtD
Roflumilast—Rash—Didanosine—acquired immunodeficiency syndrome	0.00136	0.00145	CcSEcCtD
Roflumilast—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00144	CcSEcCtD
Roflumilast—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00136	0.00144	CcSEcCtD
Roflumilast—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00136	0.00144	CcSEcCtD
Roflumilast—Headache—Didanosine—acquired immunodeficiency syndrome	0.00135	0.00144	CcSEcCtD
Roflumilast—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00135	0.00143	CcSEcCtD
Roflumilast—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00143	CcSEcCtD
Roflumilast—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00134	0.00143	CcSEcCtD
Roflumilast—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00134	0.00143	CcSEcCtD
Roflumilast—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00142	CcSEcCtD
Roflumilast—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00142	CcSEcCtD
Roflumilast—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00142	CcSEcCtD
Roflumilast—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00141	CcSEcCtD
Roflumilast—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00141	CcSEcCtD
Roflumilast—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00133	0.00141	CcSEcCtD
Roflumilast—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00132	0.00141	CcSEcCtD
Roflumilast—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.0014	CcSEcCtD
Roflumilast—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00132	0.0014	CcSEcCtD
Roflumilast—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00131	0.0014	CcSEcCtD
Roflumilast—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.0014	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00139	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00139	CcSEcCtD
Roflumilast—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00139	CcSEcCtD
Roflumilast—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00139	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.00138	CcSEcCtD
Roflumilast—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.00138	CcSEcCtD
Roflumilast—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00129	0.00138	CcSEcCtD
Roflumilast—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00129	0.00137	CcSEcCtD
Roflumilast—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00137	CcSEcCtD
Roflumilast—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00137	CcSEcCtD
Roflumilast—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00128	0.00137	CcSEcCtD
Roflumilast—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00128	0.00136	CcSEcCtD
Roflumilast—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00128	0.00136	CcSEcCtD
Roflumilast—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00128	0.00136	CcSEcCtD
Roflumilast—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00128	0.00136	CcSEcCtD
Roflumilast—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.00135	CcSEcCtD
Roflumilast—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.00135	CcSEcCtD
Roflumilast—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00126	0.00134	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00134	CcSEcCtD
Roflumilast—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00134	CcSEcCtD
Roflumilast—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00133	CcSEcCtD
Roflumilast—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00125	0.00133	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00125	0.00132	CcSEcCtD
Roflumilast—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00132	CcSEcCtD
Roflumilast—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.00132	CcSEcCtD
Roflumilast—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00132	CcSEcCtD
Roflumilast—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00124	0.00132	CcSEcCtD
Roflumilast—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00132	CcSEcCtD
Roflumilast—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00132	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00131	CcSEcCtD
Roflumilast—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00123	0.00131	CcSEcCtD
Roflumilast—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00131	CcSEcCtD
Roflumilast—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00131	CcSEcCtD
Roflumilast—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.0013	CcSEcCtD
Roflumilast—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00122	0.0013	CcSEcCtD
Roflumilast—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00122	0.0013	CcSEcCtD
Roflumilast—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00122	0.0013	CcSEcCtD
Roflumilast—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00121	0.00129	CcSEcCtD
Roflumilast—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00129	CcSEcCtD
Roflumilast—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00129	CcSEcCtD
Roflumilast—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00128	CcSEcCtD
Roflumilast—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00128	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00128	CcSEcCtD
Roflumilast—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00128	CcSEcCtD
Roflumilast—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00127	CcSEcCtD
Roflumilast—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00127	CcSEcCtD
Roflumilast—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00127	CcSEcCtD
Roflumilast—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00119	0.00127	CcSEcCtD
Roflumilast—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00119	0.00127	CcSEcCtD
Roflumilast—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00126	CcSEcCtD
Roflumilast—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00126	CcSEcCtD
Roflumilast—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00126	CcSEcCtD
Roflumilast—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.00126	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00126	CcSEcCtD
Roflumilast—Rash—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00125	CcSEcCtD
Roflumilast—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00125	CcSEcCtD
Roflumilast—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00125	CcSEcCtD
Roflumilast—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00118	0.00125	CcSEcCtD
Roflumilast—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00125	CcSEcCtD
Roflumilast—Headache—Stavudine—acquired immunodeficiency syndrome	0.00117	0.00125	CcSEcCtD
Roflumilast—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00117	0.00125	CcSEcCtD
Roflumilast—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00124	CcSEcCtD
Roflumilast—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00124	CcSEcCtD
Roflumilast—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00117	0.00124	CcSEcCtD
Roflumilast—Rash—Abacavir—acquired immunodeficiency syndrome	0.00116	0.00124	CcSEcCtD
Roflumilast—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00116	0.00123	CcSEcCtD
Roflumilast—Headache—Abacavir—acquired immunodeficiency syndrome	0.00115	0.00123	CcSEcCtD
Roflumilast—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00123	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00123	CcSEcCtD
Roflumilast—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00115	0.00122	CcSEcCtD
Roflumilast—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00122	CcSEcCtD
Roflumilast—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00121	CcSEcCtD
Roflumilast—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00114	0.00121	CcSEcCtD
Roflumilast—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.0012	CcSEcCtD
Roflumilast—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.0012	CcSEcCtD
Roflumilast—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.0012	CcSEcCtD
Roflumilast—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00119	CcSEcCtD
Roflumilast—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00111	0.00119	CcSEcCtD
Roflumilast—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00119	CcSEcCtD
Roflumilast—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00118	CcSEcCtD
Roflumilast—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.00118	CcSEcCtD
Roflumilast—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00111	0.00118	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00118	CcSEcCtD
Roflumilast—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00117	CcSEcCtD
Roflumilast—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00117	CcSEcCtD
Roflumilast—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00109	0.00116	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00116	CcSEcCtD
Roflumilast—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00116	CcSEcCtD
Roflumilast—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00109	0.00116	CcSEcCtD
Roflumilast—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00115	CcSEcCtD
Roflumilast—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00115	CcSEcCtD
Roflumilast—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00115	CcSEcCtD
Roflumilast—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00114	CcSEcCtD
Roflumilast—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00114	CcSEcCtD
Roflumilast—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00113	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00112	CcSEcCtD
Roflumilast—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00112	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00112	CcSEcCtD
Roflumilast—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.00112	CcSEcCtD
Roflumilast—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00112	CcSEcCtD
Roflumilast—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00111	CcSEcCtD
Roflumilast—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00111	CcSEcCtD
Roflumilast—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00103	0.0011	CcSEcCtD
Roflumilast—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.0011	CcSEcCtD
Roflumilast—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.0011	CcSEcCtD
Roflumilast—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00109	CcSEcCtD
Roflumilast—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00109	CcSEcCtD
Roflumilast—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00109	CcSEcCtD
Roflumilast—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00109	CcSEcCtD
Roflumilast—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00108	CcSEcCtD
Roflumilast—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00107	CcSEcCtD
Roflumilast—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00107	CcSEcCtD
Roflumilast—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00107	CcSEcCtD
Roflumilast—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00107	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00107	CcSEcCtD
Roflumilast—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.001	0.00106	CcSEcCtD
Roflumilast—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.001	0.00106	CcSEcCtD
Roflumilast—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00106	CcSEcCtD
Roflumilast—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000995	0.00106	CcSEcCtD
Roflumilast—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000993	0.00106	CcSEcCtD
Roflumilast—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000981	0.00104	CcSEcCtD
Roflumilast—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000978	0.00104	CcSEcCtD
Roflumilast—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000967	0.00103	CcSEcCtD
Roflumilast—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000966	0.00103	CcSEcCtD
Roflumilast—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000962	0.00102	CcSEcCtD
Roflumilast—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000962	0.00102	CcSEcCtD
Roflumilast—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000957	0.00102	CcSEcCtD
Roflumilast—Rash—Indinavir—acquired immunodeficiency syndrome	0.000954	0.00101	CcSEcCtD
Roflumilast—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000953	0.00101	CcSEcCtD
Roflumilast—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000949	0.00101	CcSEcCtD
Roflumilast—Headache—Indinavir—acquired immunodeficiency syndrome	0.000948	0.00101	CcSEcCtD
Roflumilast—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000945	0.001	CcSEcCtD
Roflumilast—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000936	0.000995	CcSEcCtD
Roflumilast—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000932	0.000991	CcSEcCtD
Roflumilast—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000922	0.000981	CcSEcCtD
Roflumilast—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000918	0.000976	CcSEcCtD
Roflumilast—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000909	0.000966	CcSEcCtD
Roflumilast—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000907	0.000965	CcSEcCtD
Roflumilast—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000904	0.000962	CcSEcCtD
Roflumilast—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000901	0.000958	CcSEcCtD
Roflumilast—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.0009	0.000957	CcSEcCtD
Roflumilast—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000898	0.000955	CcSEcCtD
Roflumilast—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000897	0.000954	CcSEcCtD
Roflumilast—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000895	0.000952	CcSEcCtD
Roflumilast—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000873	0.000929	CcSEcCtD
Roflumilast—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000869	0.000925	CcSEcCtD
Roflumilast—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000865	0.00092	CcSEcCtD
Roflumilast—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000862	0.000917	CcSEcCtD
Roflumilast—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000861	0.000916	CcSEcCtD
Roflumilast—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000857	0.000911	CcSEcCtD
Roflumilast—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000855	0.00091	CcSEcCtD
Roflumilast—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000849	0.000903	CcSEcCtD
Roflumilast—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000836	0.000889	CcSEcCtD
Roflumilast—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000833	0.000886	CcSEcCtD
Roflumilast—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000833	0.000886	CcSEcCtD
Roflumilast—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000812	0.000864	CcSEcCtD
Roflumilast—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000805	0.000856	CcSEcCtD
Roflumilast—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000804	0.000855	CcSEcCtD
Roflumilast—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000797	0.000848	CcSEcCtD
Roflumilast—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000797	0.000847	CcSEcCtD
Roflumilast—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000794	0.000845	CcSEcCtD
Roflumilast—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000792	0.000842	CcSEcCtD
Roflumilast—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000774	0.000823	CcSEcCtD
Roflumilast—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000768	0.000816	CcSEcCtD
Roflumilast—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000767	0.000816	CcSEcCtD
Roflumilast—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000767	0.000815	CcSEcCtD
Roflumilast—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000762	0.000811	CcSEcCtD
Roflumilast—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000751	0.000799	CcSEcCtD
Roflumilast—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000738	0.000785	CcSEcCtD
Roflumilast—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000732	0.000778	CcSEcCtD
Roflumilast—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000731	0.000778	CcSEcCtD
Roflumilast—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000727	0.000773	CcSEcCtD
Roflumilast—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000723	0.000769	CcSEcCtD
Roflumilast—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00069	0.000733	CcSEcCtD
